This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Will Purcell

The diamond and specialty minerals stocks box score for Tuesday was a mediocre 74-67-169 as the TSX Venture Exchange rose nine points to 665. Dr. Stewart Blusson's Archon Minerals Ltd. (ACS), which trades about once every blue moon, rose one-half cent to 15 cents on 33,000 shares when it last traded two weeks ago.

Archon's primary asset is a royalty interest in the Buffer claims at Ekati, where it will collect a 2.3-per-cent gross overriding royalty should Ekati mine any kimberlites on that ground. As well, Archon still has three diamond projects in its portfolio -- Buffer, Monument and WO -- if a valuation of $1 apiece counts as being carried on its books. (It does, but it also documents the dogged nature of Dr. Blusson, a diamond rottweiler that just cannot quite let go.)

Just do not expect any work on those projects. Archon is a minority participant at WO, the old Tli Kwi Cho kimberlite that wowed and then disappointed the market 30 years ago. De Beers is the majority co-venturer and operator, although there has not been any operating to speak of over the past decade. Indeed, with De Beers shutting down its Canadian exploration program last year, WO seems destined to collect dust until it is forgotten.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS